ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The bone-protective mechanisms of active components from TCM drugs in rheumatoid arthritis treatment

Lu, Qingyi; Xu, Jie; Jiang, Haixu; Wei, Qiuzhu; Huang, Runyue*; Huang, Guangrui*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2022-10-25DOI: 10.3389/fphar.2022.1000865
1被引7阅读
引用收藏
分享

摘要

Rheumatoid arthritis (RA) is an autoimmune disease whose hallmarks are synovial inflammation and irreversible bone destruction. Bone resorption resulting from osteoclasts involves the whole immune and bone systems. Breakdown of bone remodeling is attributed to overactive immune cells that produce large quantities of cytokines, upregulated differentiation of osteoclasts with enhanced resorptive activities, suppressed differentiation of osteoblasts, invading fibroblasts and microbiota dysbiosis. Despite the mitigation of inflammation, the existing treatment in Western medicine fails to prevent bone loss during disease progression. Traditional Chinese medicine (TCM) has been used for thousands of years in RA treatment, showing great efficacy in bone preservation. The complex components from the decoctions and prescriptions exhibit various pharmacological activities. This review summarizes the research progress that has been made in terms of the bone-protective effect of some representative compounds from TCM drugs and proposes the substantial mechanisms involved in bone metabolism to provide some clues for future studies. These active components systemically suppress bone destruction via inhibiting joint inflammation, osteoclast differentiation, and fibroblast proliferation. Neutrophil, gut microenvironment and microRNA has been proposed as future focus.

学科与关键词

关键词
rheumatoid arthritistraditional Chinese medicineosteoclastactive componentsbone protectionbone destruction
相关
加载中…
  • Research progress of plant medicine and Chinese herbal compounds in the treatment of rheumatoid arthritis combined with osteoporosis
    Gu, Zhuoxu; Zhou, Guanghui; Zhang, Xianquan; Liang, Guihong; Xiao, Xiao*; Dou, Yaoxing*Frontiers in Medicine, 2024, 10: 1288591.
  • An integrative pharmacology model for decoding the underlying Therapeutic Mechanisms of Ermiao Powder for Rheumatoid arthritis (vol 13, 801350, 2022)
    Wu, Jie; Wang, Kexin; Liu, Qinwen; Li, Yi; Huang, Yingying; Liu, Yujie; Cai, Jieqi; Yin, Chuanhui; Li, Xiaowei; Yu, Hailang; Meng, Wei; Wang, Handuo; Lu, Aiping*; Li, Yazi; Guan, Daogang*Frontiers in Pharmacology, 2023, 14: 1302388.
  • Mechanism underlying the action of Duanteng-Yimu Tang in regulating Treg/Th17 imbalance and anti-rheumatoid arthritis
    Feng, Wei; Wan, Xin; Fan, Shirong; Liu, Cui-Zhen; Zheng, Xue-Xia; Liu, Qing-Ping; Liu, Min-Ying; Liu, Xiao-Bao; Lin, Chang-Song; Zhang, Li-juan*; Li, De -tang*; Xu, Qiang*Heliyon, 2023, 9(5): e15867.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-10-25
卷期
第 13 卷
页码
1000865
DOI
10.3389/fphar.2022.1000865
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China; Research Program from Beijing University of Chinese Medicine; Beijing Science and Technology Commission; [82205068]; [81904142]; [2021-JYB-XJSJJ-023]; [Z191100001519006]

作者

  • L

    Lu, Qingyi (第一作者)

    beijing univ chinese med

  • X

    Xu, Jie

    beijing univ chinese med

查看全部 6 位作者收起作者
  • J

    Jiang, Haixu

    beijing univ chinese med

  • W

    Wei, Qiuzhu

    beijing univ chinese med

  • H

    Huang, Runyue (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Huang, Guangrui (通讯)

    beijing univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417